查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1812387

類器官市場

Organoids Market
出版日期: | 出版商: Transparency Market Research | 英文 206 Pages | 商品交期: 2-10個工作天內

價格

類器官市場-報告範圍

TMR 的全球類器官市場報告研究了過去和當前的成長趨勢和機遇，以獲得 2025 年至 2035 年預測期內市場指標的寶貴見解。該報告提供了 2025 年至 2035 年期間全球類器官市場的收入，以 2025 年為基準年，2035 年為預測年。報告中也提供了 2025 年至 2035 年全球類器官市場的年複合成長率(CAGR %)。

本報告經過廣泛的研究後編寫。主要研究工作量較大，分析師訪問了關鍵意見領袖、產業領袖和輿論領袖。次要研究則參考了主要廠商的產品資料、年度報告、新聞稿和相關文件，以了解二輪車導航顯示器市場。

市場概況
2024年的市場價值 11億美元
2035年的市場價值 42億美元
複合年成長率 13.4%

本報告深入探討了全球二輪車導航顯示器市場的競爭格局。該報告已確定全球類器官市場的主要參與者，並根據其各項屬性對每位參與者進行了分析。本報告涵蓋了全球類器官市場參與者的屬性，包括公司概況、財務狀況、近期發展和 SWOT 分析。

全球類器官市場報告解答的關鍵問題：

  • 預測期內，所有地區的血液分離術銷售額/收入為何？
  • 全球二輪車導航顯示器市場有哪些機會？
  • 市場的主要促進因素、限制因素、機會和威脅是什麼？
  • 在預測期內，哪個區域市場將以最快的複合年成長率擴張？
  • 預計哪個領域將在 2035 年創造全球最高收入？
  • 預測期內，哪個細分市場預計以最高複合年成長率擴張？
  • 在全球市場中經營的不同公司的市場地位如何？

類器官市場—研究目標與研究方法

這份關於全球類器官市場的綜合報告首先概述了研究範圍和目標。報告詳細闡述了本研究的目標、市場中的主要供應商和分銷商，以及產品核准的監管情況。

為了方便閱讀，本報告採用章節式編排，每個章節又細分為多個小節。報告包含詳盡的圖表，並適當穿插。各關鍵細分市場的實際值和預測值以圖形方式呈現，視覺上引人入勝。此外，報告也便於讀者比較過去和預測期末各關鍵細分市場的市佔率。

本報告從產品、最終用戶和地區角度分析了全球類器官市場。該報告對每個標準下的關鍵細分市場進行了深入研究，並提供了2035年底每個細分市場的市場佔有率。這些寶貴的見解使市場利益相關者能夠在全球二輪車導航顯示器市場投資時做出明智的商業決策。

目錄

第1章：前言

第2章：假設與研究方法

第3章：執行摘要：全球市場

第4章：市場概況

  • 介紹
  • 概述
  • 市場動態
  • 2020年至2035年全球類器官市場分析與預測

第5章：關鍵見解

  • 主要地區/國家的醫療保健支出
  • 類器官技術的最新進展
  • 類器官的定價趨勢
  • 主要地區/國家的監管情況
  • 波特五力分析
  • PESTEL分析
  • 價值鏈分析
  • 最終用戶的關鍵購買指標
  • 新市場進入者的市場進入策略
  • 重要產業事件（合作夥伴關係、協作、產品核准、併購）
  • 主要競爭對手提供的關鍵產品的基準化分析

第6章：全球市場分析與預測：按類器官類型

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年各類類器官市場價值預測
    • 胃類器官
    • 腸道類器官
    • 肝臟類器官
    • 肺類器官
    • 腦類器官
    • 腎臟類器官
    • 大腸直腸類器官
    • 乳腺類器官
    • 前列腺類器官
    • 皮膚類器官
    • 視網膜類器官
    • 其他
  • 不同類型類器官的市場吸引力

第7章：全球市場分析與預測：依來源

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年各來源市場價值預測
    • 多能幹細胞（PSC）
      • 胚胎幹細胞（ESC）
      • 誘導性多能幹細胞（iPSC）
    • 成體幹細胞（ASC）
    • 患者來源的類器官
  • 市場吸引力（按來源）

第8章：全球市場分析與預測：按應用

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年各應用市場價值預測
    • 發育生物學
    • 再生醫學
    • 疾病建模
    • 藥物毒性和療效測試
    • 生物標記發現
    • 其他
  • 按應用分類的市場吸引力

第9章：全球市場分析與預測：按可用性

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年可用性市值預測
    • 即用型類器官
    • 可自訂的類器官
  • 可用性的市場吸引力

第10章：全球市場分析與預測：依儲存條件

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年按儲存條件分類的市場價值預測
    • 耐儲存的類器官
    • 冷凍保存的類器官
  • 不同儲存條件的市場吸引力

第 11 章：全球市場分析與預測：按最終用戶

  • 介紹與定義
  • 主要發現/進展
  • 2020 年至 2035 年終端用戶市場價值預測
    • 製藥和生物技術公司
    • 合約研究組織（CRO）
    • 學術和研究機構
  • 最終用戶的市場吸引力

第12章：全球市場分析及預測：按地區

  • 主要發現
  • 各地區市場價值預測
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 各地區市場吸引力

第13章：北美市場分析與預測

  • 美國
  • 加拿大

第14章：歐洲市場分析與預測

  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 瑞士
  • 荷蘭
  • 歐洲其他地區

第15章：亞太市場分析與預測

  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲和紐西蘭
  • 亞太其他地區

第16章：拉丁美洲市場分析與預測

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區

第 17 章：中東和非洲市場分析與預測

  • 海灣合作理事會國家
  • 南非
  • 中東和非洲其他地區

第 18 章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 各公司市佔率分析（2024年）
  • 公司簡介
    • Danaher Corporation
    • Merck KGaA
    • 3Dnamics Inc.
    • ATCC
    • STEMCELL Technologies
    • CelVivo ApS
    • Emulate, Inc.
    • Newcells Biotech
    • ACROBiosystems
    • Corning Incorporated
    • Pandorum Technologies Pvt. Ltd.
    • MIMETAS BV
    • Organovo Holdings Inc.
    • Crown Bioscience
    • OrganoTherapeutics SARL
Product Code: TMRGL73363

Organoids Market- Scope of Report

TMR's report on the global Organoids Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Organoids Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Organoids Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Organoids Market .

Market Snapshot
Market Value in 2024US$ 1.1 Bn
Market Value in 2035US$ 4.2 Bn
CAGR13.4%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Organoids Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Organoids Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Organoids Market .

The report delves into the competitive landscape of the global Organoids Market . Key players operating in the global Organoids Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Organoids Marketprofiled in this report.

Key Questions Answered in Global Organoids MarketReport:

  • What are the opportunities in the global Organoids Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Organoids Market- Research Objectives and Research Approach

The comprehensive report on the global Organoids Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Organoids Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Organoids Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Organoids Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Organoids Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Recent Advancements in Organoid Technology
  • 5.3. Pricing Trends for Organoids
  • 5.4. Regulatory Scenario across Key Regions / Countries
  • 5.5. PORTER's Five Forces Analysis
  • 5.6. PESTEL Analysis
  • 5.7. Value Chain Analysis
  • 5.8. Key Purchase Metrics for End-users
  • 5.9. Go-to-Market Strategy for New Market Entrants
  • 5.10. Key Industry Events (Partnerships, Collaborations, Product approvals, mergers & acquisitions)
  • 5.11. Benchmarking of Key Products Offered by the Leading Competitors

6. Global Organoids Market Analysis and Forecasts, By Type of Organoid

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 6.3.1. Stomach Organoids
    • 6.3.2. Intestinal Organoids
    • 6.3.3. Liver Organoids
    • 6.3.4. Lung Organoids
    • 6.3.5. Brain Organoids
    • 6.3.6. Kidney Organoids
    • 6.3.7. Colorectal Organoids
    • 6.3.8. Breast Organoids
    • 6.3.9. Prostate Organoids
    • 6.3.10. Skin Organoids
    • 6.3.11. Retina Organoids
    • 6.3.12. Others
  • 6.4. Market Attractiveness By Type of Organoid

7. Global Organoids Market Analysis and Forecasts, By Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Source, 2020 to 2035
    • 7.3.1. Pluripotent Stem Cells (PSCs)
      • 7.3.1.1. Embryonic Stem Cells (ESCs)
      • 7.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 7.3.2. Adult Stem Cells (ASCs)
    • 7.3.3. Patient-derived Organoids
  • 7.4. Market Attractiveness By Source

8. Global Organoids Market Analysis and Forecasts, By Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Application, 2020 to 2035
    • 8.3.1. Developmental Biology
    • 8.3.2. Regenerative Medicine
    • 8.3.3. Disease Modelling
    • 8.3.4. Drug Toxicity and Efficacy Testing
    • 8.3.5. Biomarker Discovery
    • 8.3.6. Others
  • 8.4. Market Attractiveness By Application

9. Global Organoids Market Analysis and Forecasts, By Usability

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Usability, 2020 to 2035
    • 9.3.1. Ready-to-Use Organoids
    • 9.3.2. Customizable Organoids
  • 9.4. Market Attractiveness By Usability

10. Global Organoids Market Analysis and Forecasts, By Storage Conditions

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 10.3.1. Shelf-stable Organoids
    • 10.3.2. Cryopreserved Organoids
  • 10.4. Market Attractiveness By Storage Conditions

11. Global Organoids Market Analysis and Forecasts, By End-user

  • 11.1. Introduction & Definition
  • 11.2. Key Findings / Developments
  • 11.3. Market Value Forecast By End-user, 2020 to 2035
    • 11.3.1. Pharmaceutical and Biotechnology Companies
    • 11.3.2. Contract Research Organizations (CROs)
    • 11.3.3. Academic and Research Institutions
  • 11.4. Market Attractiveness By End-user

12. Global Organoids Market Analysis and Forecasts, By Region

  • 12.1. Key Findings
  • 12.2. Market Value Forecast By Region
    • 12.2.1. North America
    • 12.2.2. Europe
    • 12.2.3. Asia Pacific
    • 12.2.4. Latin America
    • 12.2.5. Middle East & Africa
  • 12.3. Market Attractiveness By Region

13. North America Organoids Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 13.2.1. Stomach Organoids
    • 13.2.2. Intestinal Organoids
    • 13.2.3. Liver Organoids
    • 13.2.4. Lung Organoids
    • 13.2.5. Brain Organoids
    • 13.2.6. Kidney Organoids
    • 13.2.7. Colorectal Organoids
    • 13.2.8. Breast Organoids
    • 13.2.9. Prostate Organoids
    • 13.2.10. Skin Organoids
    • 13.2.11. Retina Organoids
    • 13.2.12. Others
  • 13.3. Market Value Forecast By Source, 2020 to 2035
    • 13.3.1. Pluripotent Stem Cells (PSCs)
      • 13.3.1.1. Embryonic Stem Cells (ESCs)
      • 13.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 13.3.2. Adult Stem Cells (ASCs)
    • 13.3.3. Patient-derived Organoids
  • 13.4. Market Value Forecast By Application, 2020 to 2035
    • 13.4.1. Developmental Biology
    • 13.4.2. Regenerative Medicine
    • 13.4.3. Disease Modelling
    • 13.4.4. Drug Toxicity and Efficacy Testing
    • 13.4.5. Biomarker Discovery
    • 13.4.6. Others
  • 13.5. Market Value Forecast By Usability, 2020 to 2035
    • 13.5.1. Ready-to-Use Organoids
    • 13.5.2. Customizable Organoids
  • 13.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 13.6.1. Shelf-stable Organoids
    • 13.6.2. Cryopreserved Organoids
  • 13.7. Market Value Forecast By End-user, 2020 to 2035
    • 13.7.1. Pharmaceutical and Biotechnology Companies
    • 13.7.2. Contract Research Organizations (CROs)
    • 13.7.3. Academic and Research Institutions
  • 13.8. Market Value Forecast By Country , 2020 to 2035
    • 13.8.1. U.S.
    • 13.8.2. Canada
  • 13.9. Market Attractiveness Analysis
    • 13.9.1. By Type of Organoid
    • 13.9.2. By Source
    • 13.9.3. By Application
    • 13.9.4. By Usability
    • 13.9.5. By Storage Conditions
    • 13.9.6. By End-user
    • 13.9.7. By Country

14. Europe Organoids Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 14.2.1. Stomach Organoids
    • 14.2.2. Intestinal Organoids
    • 14.2.3. Liver Organoids
    • 14.2.4. Lung Organoids
    • 14.2.5. Brain Organoids
    • 14.2.6. Kidney Organoids
    • 14.2.7. Colorectal Organoids
    • 14.2.8. Breast Organoids
    • 14.2.9. Prostate Organoids
    • 14.2.10. Skin Organoids
    • 14.2.11. Retina Organoids
    • 14.2.12. Others
  • 14.3. Market Value Forecast By Source, 2020 to 2035
    • 14.3.1. Pluripotent Stem Cells (PSCs)
      • 14.3.1.1. Embryonic Stem Cells (ESCs)
      • 14.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 14.3.2. Adult Stem Cells (ASCs)
    • 14.3.3. Patient-derived Organoids
  • 14.4. Market Value Forecast By Application, 2020 to 2035
    • 14.4.1. Developmental Biology
    • 14.4.2. Regenerative Medicine
    • 14.4.3. Disease Modelling
    • 14.4.4. Drug Toxicity and Efficacy Testing
    • 14.4.5. Biomarker Discovery
    • 14.4.6. Others
  • 14.5. Market Value Forecast By Usability, 2020 to 2035
    • 14.5.1. Ready-to-Use Organoids
    • 14.5.2. Customizable Organoids
  • 14.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 14.6.1. Shelf-stable Organoids
    • 14.6.2. Cryopreserved Organoids
  • 14.7. Market Value Forecast By End-user, 2020 to 2035
    • 14.7.1. Pharmaceutical and Biotechnology Companies
    • 14.7.2. Contract Research Organizations (CROs)
    • 14.7.3. Academic and Research Institutions
  • 14.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 14.8.1. Germany
    • 14.8.2. UK
    • 14.8.3. France
    • 14.8.4. Italy
    • 14.8.5. Spain
    • 14.8.6. Switzerland
    • 14.8.7. The Netherlands
    • 14.8.8. Rest of Europe
  • 14.9. Market Attractiveness Analysis
    • 14.9.1. By Type of Organoid
    • 14.9.2. By Source
    • 14.9.3. By Application
    • 14.9.4. By Usability
    • 14.9.5. By Storage Conditions
    • 14.9.6. By End-user
    • 14.9.7. By Country / Sub-region

15. Asia Pacific Organoids Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 15.2.1. Stomach Organoids
    • 15.2.2. Intestinal Organoids
    • 15.2.3. Liver Organoids
    • 15.2.4. Lung Organoids
    • 15.2.5. Brain Organoids
    • 15.2.6. Kidney Organoids
    • 15.2.7. Colorectal Organoids
    • 15.2.8. Breast Organoids
    • 15.2.9. Prostate Organoids
    • 15.2.10. Skin Organoids
    • 15.2.11. Retina Organoids
    • 15.2.12. Others
  • 15.3. Market Value Forecast By Source, 2020 to 2035
    • 15.3.1. Pluripotent Stem Cells (PSCs)
      • 15.3.1.1. Embryonic Stem Cells (ESCs)
      • 15.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 15.3.2. Adult Stem Cells (ASCs)
    • 15.3.3. Patient-derived Organoids
  • 15.4. Market Value Forecast By Application, 2020 to 2035
    • 15.4.1. Developmental Biology
    • 15.4.2. Regenerative Medicine
    • 15.4.3. Disease Modelling
    • 15.4.4. Drug Toxicity and Efficacy Testing
    • 15.4.5. Biomarker Discovery
    • 15.4.6. Others
  • 15.5. Market Value Forecast By Usability, 2020 to 2035
    • 15.5.1. Ready-to-Use Organoids
    • 15.5.2. Customizable Organoids
  • 15.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 15.6.1. Shelf-stable Organoids
    • 15.6.2. Cryopreserved Organoids
  • 15.7. Market Value Forecast By End-user, 2020 to 2035
    • 15.7.1. Pharmaceutical and Biotechnology Companies
    • 15.7.2. Contract Research Organizations (CROs)
    • 15.7.3. Academic and Research Institutions
  • 15.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 15.8.1. China
    • 15.8.2. India
    • 15.8.3. Japan
    • 15.8.4. South Korea
    • 15.8.5. Australia & New Zealand
    • 15.8.6. Rest of Asia Pacific
  • 15.9. Market Attractiveness Analysis
    • 15.9.1. By Type of Organoid
    • 15.9.2. By Source
    • 15.9.3. By Application
    • 15.9.4. By Usability
    • 15.9.5. By Storage Conditions
    • 15.9.6. By End-user
    • 15.9.7. By Country / Sub-region

16. Latin America Organoids Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 16.2.1. Stomach Organoids
    • 16.2.2. Intestinal Organoids
    • 16.2.3. Liver Organoids
    • 16.2.4. Lung Organoids
    • 16.2.5. Brain Organoids
    • 16.2.6. Kidney Organoids
    • 16.2.7. Colorectal Organoids
    • 16.2.8. Breast Organoids
    • 16.2.9. Prostate Organoids
    • 16.2.10. Skin Organoids
    • 16.2.11. Retina Organoids
    • 16.2.12. Others
  • 16.3. Market Value Forecast By Source, 2020 to 2035
    • 16.3.1. Pluripotent Stem Cells (PSCs)
      • 16.3.1.1. Embryonic Stem Cells (ESCs)
      • 16.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 16.3.2. Adult Stem Cells (ASCs)
    • 16.3.3. Patient-derived Organoids
  • 16.4. Market Value Forecast By Application, 2020 to 2035
    • 16.4.1. Developmental Biology
    • 16.4.2. Regenerative Medicine
    • 16.4.3. Disease Modelling
    • 16.4.4. Drug Toxicity and Efficacy Testing
    • 16.4.5. Biomarker Discovery
    • 16.4.6. Others
  • 16.5. Market Value Forecast By Usability, 2020 to 2035
    • 16.5.1. Ready-to-Use Organoids
    • 16.5.2. Customizable Organoids
  • 16.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 16.6.1. Shelf-stable Organoids
    • 16.6.2. Cryopreserved Organoids
  • 16.7. Market Value Forecast By End-user, 2020 to 2035
    • 16.7.1. Pharmaceutical and Biotechnology Companies
    • 16.7.2. Contract Research Organizations (CROs)
    • 16.7.3. Academic and Research Institutions
  • 16.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 16.8.1. Brazil
    • 16.8.2. Mexico
    • 16.8.3. Argentina
    • 16.8.4. Rest of Latin America
  • 16.9. Market Attractiveness Analysis
    • 16.9.1. By Type of Organoid
    • 16.9.2. By Source
    • 16.9.3. By Application
    • 16.9.4. By Usability
    • 16.9.5. By Storage Conditions
    • 16.9.6. By End-user
    • 16.9.7. By Country / Sub-region

17. Middle East & Africa Organoids Market Analysis and Forecast

  • 17.1. Introduction
    • 17.1.1. Key Findings
  • 17.2. Market Value Forecast By Type of Organoid, 2020 to 2035
    • 17.2.1. Stomach Organoids
    • 17.2.2. Intestinal Organoids
    • 17.2.3. Liver Organoids
    • 17.2.4. Lung Organoids
    • 17.2.5. Brain Organoids
    • 17.2.6. Kidney Organoids
    • 17.2.7. Colorectal Organoids
    • 17.2.8. Breast Organoids
    • 17.2.9. Prostate Organoids
    • 17.2.10. Skin Organoids
    • 17.2.11. Retina Organoids
    • 17.2.12. Others
  • 17.3. Market Value Forecast By Source, 2020 to 2035
    • 17.3.1. Pluripotent Stem Cells (PSCs)
      • 17.3.1.1. Embryonic Stem Cells (ESCs)
      • 17.3.1.2. Induced Pluripotent Stem Cells (iPSCs)
    • 17.3.2. Adult Stem Cells (ASCs)
    • 17.3.3. Patient-derived Organoids
  • 17.4. Market Value Forecast By Application, 2020 to 2035
    • 17.4.1. Developmental Biology
    • 17.4.2. Regenerative Medicine
    • 17.4.3. Disease Modelling
    • 17.4.4. Drug Toxicity and Efficacy Testing
    • 17.4.5. Biomarker Discovery
    • 17.4.6. Others
  • 17.5. Market Value Forecast By Usability, 2020 to 2035
    • 17.5.1. Ready-to-Use Organoids
    • 17.5.2. Customizable Organoids
  • 17.6. Market Value Forecast By Storage Conditions, 2020 to 2035
    • 17.6.1. Shelf-stable Organoids
    • 17.6.2. Cryopreserved Organoids
  • 17.7. Market Value Forecast By End-user, 2020 to 2035
    • 17.7.1. Pharmaceutical and Biotechnology Companies
    • 17.7.2. Contract Research Organizations (CROs)
    • 17.7.3. Academic and Research Institutions
  • 17.8. Market Value Forecast By Country / Sub-region , 2020 to 2035
    • 17.8.1. GCC Countries
    • 17.8.2. South Africa
    • 17.8.3. Rest of Middle East & Africa
  • 17.9. Market Attractiveness Analysis
    • 17.9.1. By Type of Organoid
    • 17.9.2. By Source
    • 17.9.3. By Application
    • 17.9.4. By Usability
    • 17.9.5. By Storage Conditions
    • 17.9.6. By End-user
    • 17.9.7. By Country / Sub-region

18. Competition Landscape

  • 18.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 18.2. Market Share Analysis By Company (2024)
  • 18.3. Company Profiles
    • 18.3.1. Danaher Corporation
      • 18.3.1.1. Company Overview
      • 18.3.1.2. Financial Overview
      • 18.3.1.3. Product Portfolio
      • 18.3.1.4. Business Strategies
      • 18.3.1.5. Recent Developments
    • 18.3.2. Merck KGaA
      • 18.3.2.1. Company Overview
      • 18.3.2.2. Financial Overview
      • 18.3.2.3. Product Portfolio
      • 18.3.2.4. Business Strategies
      • 18.3.2.5. Recent Developments
    • 18.3.3. 3Dnamics Inc.
      • 18.3.3.1. Company Overview
      • 18.3.3.2. Financial Overview
      • 18.3.3.3. Product Portfolio
      • 18.3.3.4. Business Strategies
      • 18.3.3.5. Recent Developments
    • 18.3.4. ATCC
      • 18.3.4.1. Company Overview
      • 18.3.4.2. Financial Overview
      • 18.3.4.3. Product Portfolio
      • 18.3.4.4. Business Strategies
      • 18.3.4.5. Recent Developments
    • 18.3.5. STEMCELL Technologies
      • 18.3.5.1. Company Overview
      • 18.3.5.2. Financial Overview
      • 18.3.5.3. Product Portfolio
      • 18.3.5.4. Business Strategies
      • 18.3.5.5. Recent Developments
    • 18.3.6. CelVivo ApS
      • 18.3.6.1. Company Overview
      • 18.3.6.2. Financial Overview
      • 18.3.6.3. Product Portfolio
      • 18.3.6.4. Business Strategies
      • 18.3.6.5. Recent Developments
    • 18.3.7. Emulate, Inc.
      • 18.3.7.1. Company Overview
      • 18.3.7.2. Financial Overview
      • 18.3.7.3. Product Portfolio
      • 18.3.7.4. Business Strategies
      • 18.3.7.5. Recent Developments
    • 18.3.8. Newcells Biotech
      • 18.3.8.1. Company Overview
      • 18.3.8.2. Financial Overview
      • 18.3.8.3. Product Portfolio
      • 18.3.8.4. Business Strategies
      • 18.3.8.5. Recent Developments
    • 18.3.9. ACROBiosystems
      • 18.3.9.1. Company Overview
      • 18.3.9.2. Financial Overview
      • 18.3.9.3. Product Portfolio
      • 18.3.9.4. Business Strategies
      • 18.3.9.5. Recent Developments
    • 18.3.10. Corning Incorporated
      • 18.3.10.1. Company Overview
      • 18.3.10.2. Financial Overview
      • 18.3.10.3. Product Portfolio
      • 18.3.10.4. Business Strategies
      • 18.3.10.5. Recent Developments
    • 18.3.11. Pandorum Technologies Pvt. Ltd.
      • 18.3.11.1. Company Overview
      • 18.3.11.2. Financial Overview
      • 18.3.11.3. Product Portfolio
      • 18.3.11.4. Business Strategies
      • 18.3.11.5. Recent Developments
    • 18.3.12. MIMETAS B.V.
      • 18.3.12.1. Company Overview
      • 18.3.12.2. Financial Overview
      • 18.3.12.3. Product Portfolio
      • 18.3.12.4. Business Strategies
      • 18.3.12.5. Recent Developments
    • 18.3.13. Organovo Holdings Inc.
      • 18.3.13.1. Company Overview
      • 18.3.13.2. Financial Overview
      • 18.3.13.3. Product Portfolio
      • 18.3.13.4. Business Strategies
      • 18.3.13.5. Recent Developments
    • 18.3.14. Crown Bioscience
      • 18.3.14.1. Company Overview
      • 18.3.14.2. Financial Overview
      • 18.3.14.3. Product Portfolio
      • 18.3.14.4. Business Strategies
      • 18.3.14.5. Recent Developments
    • 18.3.15. OrganoTherapeutics SARL
      • 18.3.15.1. Company Overview
      • 18.3.15.2. Financial Overview
      • 18.3.15.3. Product Portfolio
      • 18.3.15.4. Business Strategies
      • 18.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 02: Global Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 03: Global Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 04: Global Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 05: Global Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 06: Global Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 07: Global Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 08: Global Organoids Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 09: North America Organoids Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 10: North America Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 11: North America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 12: North America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 13: North America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 14: North America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 15: North America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 16: North America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 17: Europe Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 18: Europe Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 19: Europe Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 20: Europe Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 21: Europe Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 22: Europe Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 23: Europe Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 24: Europe Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 25: Asia Pacific Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 27: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 28: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 29: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 30: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 31: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 32: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 33: Latin America Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 34: Asia Pacific Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 35: Latin America Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 36: Latin America Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 37: Latin America Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 38: Latin America Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 39: Latin America Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 40: Latin America Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 41: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 42: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Type of Organoid, 2020 to 2035
  • Table 43: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Source, 2020 to 2035
  • Table 44: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Table 45: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Application, 2020 to 2035
  • Table 46: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Usability, 2020 to 2035
  • Table 47: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By Storage Conditions, 2020 to 2035
  • Table 48: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035

List of Figures

  • Figure 01: Global Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 02: Global Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 03: Global Organoids Market Revenue (US$ Bn), by Stomach Organoids, 2020 to 2035
  • Figure 04: Global Organoids Market Revenue (US$ Bn), by Intestinal Organoids, 2020 to 2035
  • Figure 05: Global Organoids Market Revenue (US$ Bn), by Liver Organoids, 2020 to 2035
  • Figure 06: Global Organoids Market Revenue (US$ Bn), by Lung Organoids, 2020 to 2035
  • Figure 07: Global Organoids Market Revenue (US$ Bn), by Brain Organoids, 2020 to 2035
  • Figure 08: Global Organoids Market Revenue (US$ Bn), by Kidney Organoids, 2020 to 2035
  • Figure 09: Global Organoids Market Revenue (US$ Bn), by Colorectal Organoids, 2020 to 2035
  • Figure 10: Global Organoids Market Revenue (US$ Bn), by Breast Organoids, 2020 to 2035
  • Figure 11: Global Organoids Market Revenue (US$ Bn), by Prostate Organoids, 2020 to 2035
  • Figure 12: Global Organoids Market Revenue (US$ Bn), by Skin Organoids, 2020 to 2035
  • Figure 13: Global Organoids Market Revenue (US$ Bn), by Retina Organoids, 2020 to 2035
  • Figure 14: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 15: Global Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 16: Global Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 17: Global Organoids Market Revenue (US$ Bn), by Pluripotent Stem Cells (PSCs), 2020 to 2035
  • Figure 18: Global Organoids Market Revenue (US$ Bn), by Adult Stem Cells (ASCs), 2020 to 2035
  • Figure 19: Global Organoids Market Revenue (US$ Bn), by Patient-derived Organoids, 2020 to 2035
  • Figure 20: Global Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 21: Global Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 22: Global Organoids Market Revenue (US$ Bn), by Developmental Biology, 2020 to 2035
  • Figure 23: Global Organoids Market Revenue (US$ Bn), by Regenerative Medicine, 2020 to 2035
  • Figure 24: Global Organoids Market Revenue (US$ Bn), by Disease Modelling, 2020 to 2035
  • Figure 25: Global Organoids Market Revenue (US$ Bn), by Drug Toxicity and Efficacy Testing, 2020 to 2035
  • Figure 26: Global Organoids Market Revenue (US$ Bn), by Biomarker Discovery, 2020 to 2035
  • Figure 27: Global Organoids Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 28: Global Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 29: Global Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 30: Global Organoids Market Revenue (US$ Bn), by Ready-to-Use Organoids, 2020 to 2035
  • Figure 31: Global Organoids Market Revenue (US$ Bn), by Customizable Organoids, 2020 to 2035
  • Figure 32: Global Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 33: Global Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 34: Global Organoids Market Revenue (US$ Bn), by Shelf-stable Organoids, 2020 to 2035
  • Figure 35: Global Organoids Market Revenue (US$ Bn), by Cryopreserved Organoids, 2020 to 2035
  • Figure 36: Global Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 37: Global Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 38: Global Organoids Market Revenue (US$ Bn), by Pharmaceutical and Biotechnology Companies, 2020 to 2035
  • Figure 39: Global Organoids Market Revenue (US$ Bn), by Contract Research Organizations (CROs), 2020 to 2035
  • Figure 40: Global Organoids Market Revenue (US$ Bn), by Academic and Research Institutions, 2020 to 2035
  • Figure 41: Global Organoids Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 42: Global Organoids Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 43: North America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 44: North America Organoids Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 45: North America Organoids Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 46: North America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 47: North America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 48: North America Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 49: North America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 50: North America Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 51: North America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 52: North America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 53: North America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 54: North America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 55: North America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 56: North America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: North America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 58: Europe Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 59: Europe Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Europe Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 61: Europe Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 62: Europe Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 63: Europe Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 64: Europe Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 65: Europe Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 66: Europe Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 67: Europe Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 68: Europe Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 69: Europe Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 70: Europe Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 71: Europe Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 72: Europe Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 73: Asia Pacific Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 74: Asia Pacific Organoids Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Asia Pacific Organoids Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 76: Asia Pacific Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 77: Asia Pacific Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 78: Asia Pacific Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 79: Asia Pacific Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 80: Asia Pacific Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 81: Asia Pacific Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 82: Asia Pacific Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 83: Asia Pacific Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 84: Asia Pacific Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 85: Asia Pacific Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 86: Asia Pacific Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 87: Asia Pacific Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 88: Latin America Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 89: Latin America Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 90: Latin America Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 91: Latin America Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 92: Latin America Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 93: Latin America Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 94: Latin America Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 95: Latin America Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 96: Latin America Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 97: Latin America Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 98: Latin America Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 99: Latin America Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 100: Latin America Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 101: Latin America Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 102: Latin America Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 103: Middle East & Africa Organoids Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 104: Middle East & Africa Organoids Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 105: Middle East & Africa Organoids Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 106: Middle East & Africa Organoids Market Value Share Analysis, By Type of Organoid, 2024 and 2035
  • Figure 107: Middle East & Africa Organoids Market Attractiveness Analysis, By Type of Organoid, 2025 to 2035
  • Figure 108: Middle East & Africa Organoids Market Value Share Analysis, By Source, 2024 and 2035
  • Figure 109: Middle East & Africa Organoids Market Attractiveness Analysis, By Source, 2025 to 2035
  • Figure 110: Middle East & Africa Organoids Market Value Share Analysis, By Application, 2024 and 2035
  • Figure 111: Middle East & Africa Organoids Market Attractiveness Analysis, By Application, 2025 to 2035
  • Figure 112: Middle East & Africa Organoids Market Value Share Analysis, By Usability, 2024 and 2035
  • Figure 113: Middle East & Africa Organoids Market Attractiveness Analysis, By Usability, 2025 to 2035
  • Figure 114: Middle East & Africa Organoids Market Value Share Analysis, By Storage Conditions, 2024 and 2035
  • Figure 115: Middle East & Africa Organoids Market Attractiveness Analysis, By Storage Conditions, 2025 to 2035
  • Figure 116: Middle East & Africa Organoids Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 117: Middle East & Africa Organoids Market Attractiveness Analysis, By End-user, 2025 to 2035